Cargando…
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
Immune checkpoint blockade (ICB) therapy potently revives T cell's response to cancer. However, patients suffered with tumors that had inadequate infiltrated immune cells only receive limited therapeutic benefits from ICB therapy. Synthetic biology promotes the alternative strategy of harnessin...
Autores principales: | Lin, Zhongda, Meng, Fanqiang, Ma, Yumeng, Zhang, Chi, Zhang, Zhirang, Yang, Zhaoxin, Li, Yuan, Hou, Linlin, Xu, Yuzhong, Liang, Xin, Zhang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542607/ https://www.ncbi.nlm.nih.gov/pubmed/37790917 http://dx.doi.org/10.1016/j.bioactmat.2023.09.007 |
Ejemplares similares
-
Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
por: Meng, Fanqiang, et al.
Publicado: (2022) -
The Immunomodulation Potential of Exosomes in Tumor Microenvironment
por: Wang, Meng, et al.
Publicado: (2021) -
Gut microbiota-mediated immunomodulation in tumor
por: Liu, Xinyi, et al.
Publicado: (2021) -
Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy
por: Li, Liyan, et al.
Publicado: (2021) -
Lymphatics in Tumor Progression and Immunomodulation
por: Li, Claire Y., et al.
Publicado: (2022)